Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease.

Clin Kidney J · 2018 · PMC6070083 · PMID 30094018

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In both cohorts there was a numerical increase in FMD following administration of ascorbic acid, which did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.